188792-70-3

Usage

Uses

Used in Pharmaceutical Industry:
Ethyl 1-Boc-4-ethyl-4-piperidine carboxylate is used as an intermediate for the production of pharmaceuticals. Its role in this industry is crucial due to its ability to serve as a building block for the synthesis of a variety of biologically active molecules, which are essential in developing new drugs and medications.
Used in Organic Synthesis:
In the field of organic chemistry, Ethyl 1-Boc-4-ethyl-4-piperidine carboxylate is utilized as a reagent in various chemical reactions. Its unique structure allows it to participate in a range of organic synthesis processes, contributing to the creation of complex organic compounds for different applications.
Used in Research and Development:
Ethyl 1-Boc-4-ethyl-4-piperidine carboxylate is also employed in research and development settings, where it aids scientists in exploring new methods of synthesis and understanding the properties of related compounds. Its versatility as a building block makes it a valuable tool for advancing knowledge in organic chemistry and pharmaceutical science.

InChI:InChI=1/C15H27NO4/c1-6-15(12(17)19-7-2)8-10-16(11-9-15)13(18)20-14(3,4)5/h6-11H2,1-5H3

Upstream product

• 75-03-6 ethyl iodide 
• 142851-03-4 1-tert-butyl 4-ethyl piperidine-1,4-dicarboxylate 
• 4111-54-0 lithium diisopropyl amide 
• 124443-68-1 1-tert-Butyl 4-methyl piperidine-1,4-dicarboxylate 
• 24424-99-5 di-tert-butyl dicarbonate 
• 1126-09-6 4-carbethoxypiperidine 

Downstream Products

• 885523-41-1 1-boc-4-ethyl-4-formylpiperidine 
• 188792-67-8 1-(tert-butoxycarbonyl)-4-ethylpiperidine-4-carboxylic acid 

Relevant academic research and scientific papers

COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR

Compounds active on c-kit protein kinases or mutant c-kit protein kinases having any mutations are described, as well as methods of making and using such compounds to treat diseases and conditions associated with aberrant activity of the c-kit protein kinases and/or mutant c-kit protein kinases.

Design, synthesis and biological evaluation of α-substituted isonipecotic acid benzothiazole analogues as potent bacterial type II topoisomerase inhibitors

The discovery and optimisation of a new class of benzothiazole small molecules that inhibit bacterial DNA gyrase and topoisomerase IV are described. Antibacterial properties have been demonstrated by activity against DNA gyrase ATPase and potent activity against Staphylococcus aureus, Enterococcus faecalis, Streptococcus pyogenes and Haemophilus influenzae. Further refinements to the scaffold designed to enhance drug-likeness included analogues bearing an α-substituent to the carboxylic acid group, resulting in excellent solubility and favourable pharmacokinetic properties.

LUPEOL-TYPE TRITERPENE DERIVATIVES AS ANTIVIRALS

The invention relates to novel lupeol-type triterpene derivatives and related compounds, and pharmaceutical compositions useful for therapeutic treatment of viral diseases and particularly HIV mediated diseases.

MELANOCORTIN RECEPTOR MODULATORS, PROCESS FOR PREPARING THEM AND USE THEREOF IN HUMAN MEDICINE AND COSMETICS

The present invention relates to novel melanocortin receptor modulators corresponding to the general formula (I) to compositions containing them, to the process for preparing them and to their use in pharmaceutical or cosmetic compositions.

Amide compounds and use of the same

An amide compound of the formula (I): wherein R is amino and the like, A is alkylene and the like, X is O, S and the like, M is arylene and the like, R1, R2, R3 and R4 are H, hydroxy and the like, R5